Chromadex Corp Ownership

CDXCDelisted Stock  USD 7.87  0.07  0.88%   
Chromadex Corp holds a total of 77.75 Million outstanding shares. Chromadex Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Chromadex Corp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Chromadex Corp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Chromadex Stock Ownership Analysis

About 35.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Chromadex Corp had 1:3 split on the 13th of April 2016. ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 115 people. For more info on Chromadex Corp please contact Frank Jaksch at 310 388 6706 or go to https://www.chromadex.com.

Chromadex Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chromadex Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chromadex Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chromadex Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Carlos Lopez 2 days ago
Insider Trading
 
Carlos Lopez 3 days ago
Insider Trading
 
Carlos Lopez few days ago
Insider Trading
 
Carlos Lopez few days ago
Insider Trading
 
Carlos Lopez few days ago
Insider Trading
 
Carlos Lopez over a week ago
Insider Trading
 
Carlos Lopez over a week ago
Insider Trading
 
Carlos Lopez over a week ago
Insider Trading
 
Carlos Lopez over a week ago
Insider Trading
 
Carlos Lopez over two weeks ago
Insider Trading
 
Carlos Lopez over two weeks ago
Insider Trading
 
Patrick Kristin over two weeks ago
Acquisition by Patrick Kristin of 20000 shares of Chromadex Corp at 1.67 subject to Rule 16b-3

Chromadex Corp Outstanding Bonds

Chromadex Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chromadex Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chromadex bonds can be classified according to their maturity, which is the date when Chromadex Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Chromadex Stock

If you are still planning to invest in Chromadex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromadex Corp's history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios